Personalized dosing study aims to help kids with arthritis
NCT ID NCT02030613
Summary
This study aimed to find the best dose of the drug etanercept for children with juvenile idiopathic arthritis (JIA). Researchers measured drug levels in the blood of 126 children already taking the medication to see if adjusting the dose based on these levels could improve treatment. The goal was to help control the disease more effectively for each individual child.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Necker
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.